Physician profile
Jonathan Adler
NPI 1063541076
$3,071.26
in general payments reported to CMS, 2019-2025
17 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $24.24 · 2021: $494 · 2022: $289 · 2023: $555 · 2024: $175 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692 · Education: $41.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,692.05 |
| Education | $41.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $989.63 | 2019-2025 | Rocklatan, Tryptyr, Rhopressa |
| Bausch & Lomb Americas INC. | $474.52 | 2023-2025 | Miebo, Xiidra |
| Allergan, INC. | $235.33 | 2021-2022 | |
| Biotissue Holdings INC. | $197.09 | 2025 | |
| Sun Pharmaceutical Industries INC. | $155.52 | 2020-2023 | Cequa |
| Ocular Therapeutix, INC. | $154.73 | 2019 | |
| Glaukos Corporation | $149.66 | 2023 | |
| Abbvie INC. | $125.12 | 2022-2025 | Alphagan P, Lumigan, Vuity |
| Amgen INC. | $122.76 | 2025 | Tepezza |
| Shire North American Group INC | $109.64 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $70.32 | 2025 | Xdemvy |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Horizon Therapeutics Plc | $63.43 | 2023 | Tepezza |
| Abiomed | $60.43 | 2023 | Impella |
| Novartis Pharmaceuticals Corporation | $52.44 | 2022-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $30.00 | 2025 | Tremfya |
| Sight Sciences, INC. | $15.93 | 2023 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.